Filament’s industry-leading IP portfolio now consists of ten patents for methods of extracting and standardizing natural psychedelic compounds
“When Filament was founded, conventional wisdom held that it was impossible to produce stable psilocin,” said
Filament has developed innovative technology to extract and standardize stable doses of natural compounds from magic mushrooms. On
Learn more about www.filament.health and on Twitter, instagram and LinkedIn.
Certain statements and information contained herein may constitute “forward-looking statements” and “forward-looking information”, respectively, under Canadian securities laws. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “anticipate”, “continue”, “estimate”, “may”, “will”, “should”. “, “believe”, “intends”, “forecasts”, “plans”, “directions” and similar expressions are intended to identify forward-looking statements or information. Forward-looking statements are not historical facts, but reflect Filament’s management’s current expectations regarding future results or events and are based on information currently available to it. Certain important factors and assumptions were applied in providing these forward-looking statements. The forward-looking statements discussed in this press release may include, but are not limited to, information regarding the impact of the patent on the Company’s business and the Company’s ability to obtain future patents. Forward-looking statements regarding the Company are based on Company estimates and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or Filament’s achievements are materially different from those expressed or implied by such forward-looking statements or forward-looking information, including the status of patent applications and the ability to obtain patents. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Filament will not update any forward-looking statements or forward-looking information that is incorporated by reference herein, except as required by applicable securities laws.
© Canada Newswire, source